Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
about
The Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiationNomograms for predicting long-term overall survival and cancer-specific survival in patients with major salivary gland cancer: a population-based study.Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine.Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignanciesReirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapy.Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.Oncocytoma of the parotid gland: a case report and review of the literature.Recurrent salivary gland cancer.Unknown primary mucoepidermoid carcinoma: diagnosis and treatment.Minor salivary gland carcinoma: a review of 35 cases.Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report.Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck.Salivary duct carcinoma: Treatment, outcomes, and patterns of failure.Human β-defensins and psoriasin/S100A7 expression in salivary glands: anti-oncogenic molecules for potential therapeutic approaches.
P2860
Q28507071-80DEC3C4-E999-4678-B179-A83B2D765EDDQ33648534-19C15917-CA12-49F1-BE10-42A2AB338F04Q33931069-B954BC80-A190-492C-874B-F2A5F5817B66Q35290247-ADBEC530-84A7-45F9-9087-C1065DA150A9Q36613546-B5ECA7AB-FBFD-4489-8076-9FAFFD248E86Q36874710-108B94F5-B279-4E95-A50D-631F91B7A536Q37684781-578CB4B8-EAB5-488F-92AE-481A6FD96BEBQ37973008-231E4845-0F5F-490B-B918-CBE5B9BEF3EEQ38211521-7C7DD0B4-0B00-4737-A5BC-8C7C0B45A749Q38615897-3D1AFB48-BFF0-4E83-996C-0CD462C9CCB1Q42233857-2F03DEFB-8EA0-4513-91D0-384206C7468EQ42936492-51375A12-975F-4C14-8067-75A57E93CF89Q43602917-68139CBF-9F89-4FCE-BF41-A57C26BB7CB0Q47569604-3E44C667-91DC-4F26-9667-0B581AD948DDQ54335180-D36782C0-AAA5-499D-B342-36F1FEC91C4A
P2860
Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
@en
Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
@nl
type
label
Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
@en
Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
@nl
prefLabel
Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
@en
Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
@nl
P1433
P1476
Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
@en
P2093
Mark Agulnik
Sujani G Surakanti
P304
P356
10.1053/J.SEMINONCOL.2008.03.009
P577
2008-06-01T00:00:00Z